Phil Ferneau

Phil Ferneau is a seasoned venture capital professional with extensive experience in the healthcare sector. As Co-Founder and Managing Partner at Borealis Ventures since 2002, Ferneau focuses on early-stage investments in life sciences, digital health, and animal health. Current roles include Board Director and Investor at Compass Therapeutics LLC, Ankyra Therapeutics, and Ovation.io, as well as investor positions at Triveni Bio and T-Cypher Bio. Additionally, Ferneau's expertise extends to advisory roles at Teckro and Orbit Discovery. With an academic background that includes an MBA from The Tuck School of Business at Dartmouth, an A.B. in Government from Dartmouth College, and a J.D. from the University of Virginia School of Law, Ferneau combines legal and business acumen to drive innovations in biotechnology and therapeutics.